| Literature DB >> 33753547 |
Jingshan Lu1, Lan Yang1, Ying Xu1, Lijing Ai1, Jian Chen1, Fangfang Xiong1, Lihuan Hu1, Huoshu Chen1, Jiyuan Liu2, Xiongbin Yan2, Huihui Huang1, Li Chen3,4, Changxi Yu3,4.
Abstract
Diabetic neuropathic pain (DNP) is a common complication of diabetes characterized by persistent pain. Emerging evidence links astrocytes to mechanical nociceptive processing, and the motor cortex (MCx) is a cerebral cortex region that is known to play a key role in pain regulation. However, the association between MCx astrocytes and DNP pathogenesis remains largely unexplored. Here, we studied this association using designer receptors exclusively activated by designer drugs to specifically manipulate MCx astrocytes. We proved that the selective inhibition of MCx astrocytes reduced DNP in streptozocin (STZ)-induced DNP models and discovered a potential mechanism by which astrocytes release cytokines, including TNF-α and IL-1β, to increase neuronal activation in the MCx, thereby regulating pain. Together, these results demonstrate a pivotal role for MCx astrocytes in DNP pathogenesis and provide new insight into DNP treatment strategies.Entities:
Keywords: DREADDs; astrocytes; diabetic neuropathic pain; motor cortex
Mesh:
Year: 2021 PMID: 33753547 PMCID: PMC8211549 DOI: 10.1523/JNEUROSCI.2566-20.2021
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167